In AML, whereas MYC downregulation correlated with BRD9 degradation in Kasumi-1 and MV4-11 cells, it did not for KO52, HEL and BRD9 degrader-sensitive SKM-1 cells. This evidence concerns the gene MYC and acute myeloid leukemia.